FDA approves IlluminOss resin for aging, osteoporosis-related fractures

A BALLOON CATHETER and optical fiber are inserted through a tiny incision, in the IlluminOss Photodynamic Bone Stabilization System. A light-sensitive glue is infused into the balloon, in images 2 and 3, then light is used to activate and rapidly harden the compound. / COURTESY ILLUMINOSS MEDICAL
A BALLOON CATHETER and optical fiber are inserted through a tiny incision, in the IlluminOss Photodynamic Bone Stabilization System. A light-sensitive glue is infused into the balloon, in images 2 and 3, then light is used to activate and rapidly harden the compound. / COURTESY ILLUMINOSS MEDICAL
EAST PROVIDENCE —IlluminOss Medical has received U.S. Food and Drug Administration clearance to use its IlluminOss Bone Stabilization System using light-sensitive resin to treat osteoporosis and age-related fractures, the company announced today. The East Providence-based, privately held, commercial-stage medical device company won FDA de novo clearance fractures of the humerus, radius and ulna from metastatic bone…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -